# Gynecologic Oncology

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/gynecologic-oncology/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 4,020 |
| Citations | 694,737 |
| h-index | 225 |
| Homepage | http://www.elsevier.com/wps/find/journaldescription.cws_home/622840/description#description |
| Open Access | false |
| ISSN-L | 0090-8258 |
| ISSNs | 0090-8258,1095-6859 |
| OpenAlex ID | https://openalex.org/S2574783 |
| Publisher | Elsevier BV |
| Works | 29,057 |

## Journal papers

Showing 12 of 90.

- [A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass](https://scholariq.org/papers/a-novel-multiple-marker-bioassay-utilizing-he4-and-ca125-for-the-prediction-of/)
- [The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass](https://scholariq.org/papers/the-use-of-multiple-novel-tumor-biomarkers-for-the-detection-of-ovarian/)
- [Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm](https://scholariq.org/papers/improved-progression-free-and-overall-survival-in-advanced-ovarian-cancer-as-a/)
- [Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy☆](https://scholariq.org/papers/retrospective-review-of-208-patients-with-leiomyosarcoma-of-the-uterus/)
- [Folate receptor alpha as a tumor target in epithelial ovarian cancer](https://scholariq.org/papers/folate-receptor-alpha-as-a-tumor-target-in-epithelial-ovarian-cancer/)
- [Follow-up after primary therapy for endometrial cancer: A systematic review](https://scholariq.org/papers/follow-up-after-primary-therapy-for-endometrial-cancer-a-systematic-review/)
- [Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline](https://scholariq.org/papers/neoadjuvant-chemotherapy-for-newly-diagnosed-advanced-ovarian-cancer-society-of-2/)
- [Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study](https://scholariq.org/papers/fixed-dose-rate-gemcitabine-plus-docetaxel-as-second-line-therapy-for-metastatic/)
- [Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I](https://scholariq.org/papers/sentinel-nodes-in-vulvar-cancer-long-term-follow-up-of-the-groningen/)
- [Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer](https://scholariq.org/papers/patterns-of-pelvic-and-paraaortic-lymph-node-involvement-in-ovarian-cancer/)
- [Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2](https://scholariq.org/papers/antitumor-activity-and-safety-of-the-parp-inhibitor-rucaparib-in-patients-with/)
- [FDG-PET for management of cervical and ovarian cancer](https://scholariq.org/papers/fdg-pet-for-management-of-cervical-and-ovarian-cancer/)

## Journal top topics

Showing 8 of 25.

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Cervical Cancer and HPV Research](https://scholariq.org/topics/cervical-cancer-and-hpv-research/)
- [Uterine Myomas and Treatments](https://scholariq.org/topics/uterine-myomas-and-treatments/)
- [Intraperitoneal and Appendiceal Malignancies](https://scholariq.org/topics/intraperitoneal-and-appendiceal-malignancies/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Gynecological conditions and treatments](https://scholariq.org/topics/gynecological-conditions-and-treatments/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.